Multiple-bar Nuss operation: an individualized treatment scheme for patients with significantly asymmetric pectus excavatum

por Ben, Xiao Song, Deng, Cheng, Tian, Dan, Tang, Ji Ming, Xie, Liang, Ye, Xiong, Zhou, Zi Hao, Zhou, Hai Yu, Zhang, Dong Kun, Shi, Rui Qing, Qiao, Gui Bin, Chen, Gang
Publicado 2020

Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study

por Wu, Shaowei, Zhan, Weijie, Liu, Lan, Xie, Daipeng, Yao, Lintong, Yao, Henian, Liao, Guoqing, Huang, Luyu, Zhou, Yubo, You, Peimeng, Huang, Zekai, Li, Qiaxuan, Xu, Bin, Wang, Siyun, Wang, Guangyi, Zhang, Dong-Kun, Qiao, Guibin, Chan, Lawrence Wing-Chi, Lanuti, Michael, Zhou, Haiyu
Publicado 2023

Pathological Responses of the Primary Tumor and Locoregional Lymph Nodes After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Cancer

por Huang, Shu Jie, Tian, Dan, Wang, Si Chao, Zeng, Rui Jie, Dong, Yue Jiao, Hong, Liang Li, Wu, Han Sheng, Xu, Fang Ping, Zhang, Dong Kun, Xie, Liang, Zhou, Hai Yu, Tang, Ji Ming, Ben, Xiao Song, Chen, Gang, Chen, Ri Xin, Tang, Yong, Qiao, Gui Bin
Publicado 2022

High SHP2 expression determines the efficacy of PD‐1/PD‐L1 inhibitors in advanced KRAS mutant non‐small cell lung cancer

por Feng, Hui‐Bo, Chen, Yu, Xie, Zhi, Jiang, Jie, Zhong, Yu‐Min, Guo, Wei‐Bang, Yan, Wen‐Qing, Lv, Zhi‐Yi, Lu, Dan‐Xia, Liang, Hong‐Ling, Xu, Fang‐Ping, Yang, Jin‐Ji, Yang, Xue‐Ning, Zhou, Qing, Zhang, Dong‐Kun, Zhang, Zhou, Chuai, Shao‐Kun, Zhang, Heng‐Hui, Wu, Yi‐Long, Zhang, Xu‐Chao
Publicado 2021

PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma

por Zhong, Yu-Min, Yin, Kai, Chen, Yu, Xie, Zhi, Lv, Zhi-Yi, Yang, Jin-Ji, Yang, Xue-Ning, Zhou, Qing, Wang, Bin-Chao, Zhong, Wen-Zhao, Gao, Ling-Ling, Zhou, Wen-Bin, Chen, Ji, Tu, Hai-Yan, Liao, Ri-Qiang, Zhang, Dong-Kun, Zhang, Shui-Lian, Lu, Dan-Xia, Zheng, Hong-Bo, Zhang, Heng-Hui, Wu, Yi-Long, Zhang, Xu-Chao
Publicado 2022